Pharming Group Nv Stock Price Prediction
| PHGUF Stock | USD 0.75 0.07 8.54% |
Oversold Vs Overbought
66
Oversold | Overbought |
Using Pharming Group hype-based prediction, you can estimate the value of Pharming Group NV from the perspective of Pharming Group response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharming Group to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Pharming because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharming Group after-hype prediction price | USD 0.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharming |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharming Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharming Group After-Hype Price Prediction Density Analysis
As far as predicting the price of Pharming Group at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharming Group or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Pharming Group, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pharming Group Estimiated After-Hype Price Volatility
In the context of predicting Pharming Group's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharming Group's historical news coverage. Pharming Group's after-hype downside and upside margins for the prediction period are 0.04 and 3.07, respectively. We have considered Pharming Group's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pharming Group is dangerous at this time. Analysis and calculation of next after-hype price of Pharming Group NV is based on 3 months time horizon.
Pharming Group Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pharming Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharming Group backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharming Group, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 2.32 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.75 | 0.75 | 0.00 |
|
Pharming Group Hype Timeline
Pharming Group NV is at this time traded for 0.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pharming is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.13%. %. The volatility of related hype on Pharming Group is about 0.0%, with the expected price after the next announcement by competition of 0.75. About 16.0% of the company shares are owned by institutional investors. The book value of Pharming Group was at this time reported as 0.3. The company had not issued any dividends in recent years. Pharming Group NV had 1:10 split on the 5th of March 2013. Assuming the 90 days horizon the next anticipated press release will be within a week. Check out Pharming Group Basic Forecasting Models to cross-verify your projections.Pharming Group Related Hype Analysis
Having access to credible news sources related to Pharming Group's direct competition is more important than ever and may enhance your ability to predict Pharming Group's future price movements. Getting to know how Pharming Group's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharming Group may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GGIFF | Garibaldi Resources Corp | 0.00 | 0 per month | 12.30 | 0.07 | 25.00 | (20.00) | 210.00 | |
| DMPZF | Dominos Pizza Group | 0.00 | 0 per month | 0.00 | (0.32) | 0.00 | 0.00 | 4.34 | |
| IGGGF | IGG Inc | 0.00 | 0 per month | 0.00 | 0.09 | 7.55 | (3.64) | 56.26 | |
| PTCHF | PureTech Health plc | 0.00 | 0 per month | 2.21 | 0.04 | 6.07 | (6.12) | 15.48 | |
| SBMFF | Sino Biopharmaceutical Limited | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | 0.00 | 23.80 |
Pharming Group Additional Predictive Modules
Most predictive techniques to examine Pharming price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharming using various technical indicators. When you analyze Pharming charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharming Group Predictive Indicators
The successful prediction of Pharming Group stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharming Group NV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharming Group based on analysis of Pharming Group hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharming Group's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharming Group's related companies.
Story Coverage note for Pharming Group
The number of cover stories for Pharming Group depends on current market conditions and Pharming Group's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharming Group is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharming Group's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pharming Group Short Properties
Pharming Group's future price predictability will typically decrease when Pharming Group's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharming Group NV often depends not only on the future outlook of the potential Pharming Group's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharming Group's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 648.7 M |
Complementary Tools for Pharming Pink Sheet analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |